Current concepts in the treatment of staphylococcal meningitis.
As natural host defences are suboptimal in cerebrospinal fluid (CSF), and since antibiotics often penetrate poorly into this body site, meningitis remains one of the most difficult infections to cure. When the responsible pathogen is killed only by a relatively high concentration of an antibiotic, or is susceptible only to drugs with moderate penetration into the CSF, then treatment becomes even more complicated. Therapy of staphylococcal meningitis poses all these problems, and is even further complicated by its frequent development in the presence of a foreign body, such as a ventriculoperitoneal or ventriculoatrial shunt. In this review, we discuss the various options open to the clinician in the treatment of meningitis caused by methicillin-susceptible and methicillin-resistant staphylococci, both in the presence and in the absence of a foreign device.
Quintiliani
R
R
Division of Infectious Diseases, Hartford Hospital, Connecticut 06115.
Cooper
B W
BW
D006020:Glycopeptides / Q000627:therapeutic use; D006801:Humans; D008581:Meningitis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D017334:Teicoplanin; D014640:Vancomycin / Q000627:therapeutic use
D006020:Glycopeptides; D017334:Teicoplanin; D014640:Vancomycin